TetraGenetics

 
  • 617-500-7471
  • Networkers
  • United States of America

About TetraGenetics

TetraGenetics is focused on the discovery and development of first-in-class biologic medicines for autoimmune diseases, oncology and pain. The company has the leading drug discovery platform (TetraExpress™) for identifying antibodies targeting ion channels and other transmembrane proteins. TetraGenetics is actively building a proprietary drug pipeline and working collaboratively with major biotech companies for antibody drug discovery.

Therapeutic Areas

Central Nervous System

Technologies

Biologics

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Sponsorship Group

Networker

Topics

Editions participated in:

June 2019